A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Lidocaine Hydrochloride, Triamcinolone Acetonide, Povidone-Iodine (Physician EZ Use Joint Tunnel and Trigger Kit II)

First FDA approval2021-12-23
Generic availableNo (brand-only)
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one
Lowest NADAC
/unit
0 NDCs benchmarked, lowest of all strengths.
Average NADAC
Across all dosage forms in distribution.
Highest NADAC
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema7 entries indexed · 4 visible
What is Lidocaine Hydrochloride, Triamcinolone Acetonide, Povidone-Iodine used for?

Lidocaine Hydrochloride, Triamcinolone Acetonide, Povidone-Iodine is a this drug class medication tracked in Medicare Part D.

Is there a generic for Lidocaine Hydrochloride, Triamcinolone Acetonide, Povidone-Iodine?

No. Lidocaine Hydrochloride, Triamcinolone Acetonide, Povidone-Iodine is brand-only with no generic equivalents currently in market.

How much does my plan pay for Lidocaine Hydrochloride, Triamcinolone Acetonide, Povidone-Iodine?

NADAC pricing data not currently available for this drug.

Is Lidocaine Hydrochloride, Triamcinolone Acetonide, Povidone-Iodine on the FDA shortage list?

No. Lidocaine Hydrochloride, Triamcinolone Acetonide, Povidone-Iodine is not currently on the FDA Drug Shortage Database.

3 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.